News
Pennant Group
PNTG · NASDAQ
$41.48+$0.82 (+2.02%)TodayMarket closed ·
Prev close $40.66
Latest news
- Press releaseGlobe Newswire
Pennant Reports Second Quarter 2026 Results
- Press releaseGlobe Newswire
Pennant Announces Second Quarter 2026 Earnings Release and Call
- News
Earnings Scheduled For May 6, 2026
- News
Pennant Gr Q1 Adj. EPS $0.32 Beats $0.31 Estimate, Sales $285.400M Beat $280.748M Estimate
- Press releaseGlobe Newswire
Pennant Reports First Quarter 2026 Results
- Press releaseGlobe Newswire
Pennant Announces First Quarter 2026 Earnings Release and Call
- News
Earnings Summary: Pennant Gr Q4
- News
Pennant Gr Q4 Adj. EPS $0.34 Beats $0.32 Estimate, Sales $289.323M Beat $274.977M Estimate
- Press releaseGlobe Newswire
Pennant Reports Fourth Quarter and Fiscal Year 2025 Results
- Press releaseGlobe Newswire
Pennant Reports Third Quarter 2025 Results
- News
Forecasting The Future: 4 Analyst Projections For Pennant Gr
- News
A Glimpse Into The Expert Outlook On Pennant Gr Through 4 Analysts
- News
Forecasting The Future: 4 Analyst Projections For Pennant Gr
- Press releaseGlobe Newswire
Pennant Reports Second Quarter 2025 Results
- News
Breaking Down Pennant Gr: 4 Analysts Share Their Views
- News
What Analysts Are Saying About Pennant Gr Stock
- Press releaseBusiness Wire
CareTrust REIT Positions for Continued Growth with New $500 Million Term Loan and New Hires
- News
A Glimpse Into The Expert Outlook On Pennant Gr Through 4 Analysts
- Press releaseGlobe Newswire
Pennant Reports First Quarter 2025 Results
- Press releaseGlobe Newswire
Pennant Reports Fourth Quarter and Fiscal Year 2024 Results
- Press releaseGlobe Newswire
Pennant Reports Third Quarter 2024 Results
- News
Assessing Pennant Gr: Insights From 6 Financial Analysts
- News
Analyst Scoreboard: 5 Ratings For Pennant Gr
- News
Analyst Expectations For Pennant Gr's Future
- Press releaseGlobe Newswire
Pennant Reports Second Quarter 2024 Results
- News
A Glimpse Into The Expert Outlook On Pennant Gr Through 5 Analysts
- Press releaseGlobe Newswire
Pennant Announces Agreement to Purchase the Assets of Signature Healthcare at Home
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.